Pharm Group | Action or Disease | Prototype |
Sedative Hypnotic Anxiolytic - Benzodiazepine | Anxiety Disorders | |
Atypical Anxiolytic/Nonbarbiturate Anxiolytic | Anxiety Disorders | |
Selective Serotonin Reuptake Inhibitors (SSRI Antidepressants) | Anxiety Disorders | |
Selective Serotonin Reuptake Inhibitors (SSRIs) | Depressive Disorders | |
Atypical Antidepressants | Depressive Disorders | |
Tricyclic Antidepressants (TCAs) | Depressive Disorders | |
Monoamine Oxidase Inhibitors (MAOIs) | Depressive Disorders | |
Mood Stabilizer | Bipolar Disorders | |
Mood Stabilizing Antiepileptic Drugs (AEDs) | Bipolar Disorders | |
Antipsychotics - 1st generation (Conventional) | Psychotic Disorders | |
Antipsychotics - 2nd generation (Atypical) | Psychotic Disorders | |
Alcohol Withdrawal & Abstinence | Substance Use Disorders | |
Opioids Withdrawal & Abstinence | Substance Use Disorders | |
Nicotine Withdrawal & Abstinence | Substance Use Disorders | |
Cholinesterase Inhibitors | Chronic Neurologic Disorders | |
Anti-Parkinson's Meds | Chronic Neurologic Disorders | |
Antiepileptics (AEDs) | Chronic Neurologic Disorders | |
Beta Adrenergic Blockers | Eye & Ear Disorders | |
Alpha 2 Adrenergic Blockers | Eye & Ear Disorders | |
Prostaglandin Analogs | Eye & Ear Disorders | |
Osmotic Agents | Eye & Ear Disorders | |
Carbonic Anhydrase Inhibitor (Systemic) | Eye & Ear Disorders | |
Antimicrobials | Eye & Ear Disorders | |
Fluoroquinolone Antibiotic Plus Steroid Medication | Eye & Ear Disorders | |
Neuromuscular Blocking Agents | Miscellaneous CNS Meds | |
Muscle Relaxants and Antispasmodics | Miscellaneous CNS Meds | |
Muscarinic Agonists | Miscellaneous CNS Meds | |
Muscarinic Antagonists | Miscellaneous CNS Meds | |
Benzodiazepines | Sedative-Hypnotics | |
Nonbenzodiazepines | Sedative-Hypnotics | |
Melatonin Agonist | Sedative-Hypnotics | |
IV Anesthetics | Sedative-Hypnotics | |